Nolan D - Search Results

1

Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs.

John M, Heckerman D, James I, Park LP, Carlson JM, Chopra A, Gaudieri S, Nolan D, Haas DW, Riddler SA, Haubrich R, Mallal S. John M, et al. Among authors: nolan d. J Immunol. 2010 Apr 15;184(8):4368-77. doi: 10.4049/jimmunol.0903745. Epub 2010 Mar 15. J Immunol. 2010. PMID: 20231689 Free PMC article.

2

Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses.

Gaudieri S, Nolan D, McKinnon E, Witt CS, Mallal S, Christiansen FT. Gaudieri S, et al. Among authors: nolan d. Mol Immunol. 2005 Feb;42(4):557-60. doi: 10.1016/j.molimm.2004.07.041. Mol Immunol. 2005. PMID: 15607813 Review.

3

Host genetics and viral infections: immunology taught by viruses, virology taught by the immune system.

Nolan D, Gaudieri S, Mallal S. Nolan D, et al. Curr Opin Immunol. 2006 Aug;18(4):413-21. doi: 10.1016/j.coi.2006.05.015. Epub 2006 Jun 13. Curr Opin Immunol. 2006. PMID: 16777398 Review.

4

Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy.

Gaudieri S, Rauch A, Pfafferott K, Barnes E, Cheng W, McCaughan G, Shackel N, Jeffrey GP, Mollison L, Baker R, Furrer H, Günthard HF, Freitas E, Humphreys I, Klenerman P, Mallal S, James I, Roberts S, Nolan D, Lucas M. Gaudieri S, et al. Among authors: nolan d. Hepatology. 2009 Apr;49(4):1069-82. doi: 10.1002/hep.22773. Hepatology. 2009. PMID: 19263475

5

Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure.

Rauch A, James I, Pfafferott K, Nolan D, Klenerman P, Cheng W, Mollison L, McCaughan G, Shackel N, Jeffrey GP, Baker R, Freitas E, Humphreys I, Furrer H, Günthard HF, Hirschel B, Mallal S, John M, Lucas M, Barnes E, Gaudieri S. Rauch A, et al. Among authors: nolan d. Hepatology. 2009 Oct;50(4):1017-29. doi: 10.1002/hep.23101. Hepatology. 2009. PMID: 19670417

6

Pharmacogenetics: a practical role in predicting antiretroviral drug toxicity?

Nolan D, Gaudieri S, Mallal S. Nolan D, et al. J HIV Ther. 2003 May;8(2):36-41. J HIV Ther. 2003. PMID: 12838163 Review.

7

Thymidine analogue-sparing highly active antiretroviral therapy (HAART).

Nolan D, Mallal S. Nolan D, et al. J HIV Ther. 2003 Feb;8(1):2-6. J HIV Ther. 2003. PMID: 12840707 Review.

8

Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.

Martin AM, Nolan D, Gaudieri S, Almeida CA, Nolan R, James I, Carvalho F, Phillips E, Christiansen FT, Purcell AW, McCluskey J, Mallal S. Martin AM, et al. Among authors: nolan d, nolan r. Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4180-5. doi: 10.1073/pnas.0307067101. Epub 2004 Mar 15. Proc Natl Acad Sci U S A. 2004. PMID: 15024131 Free PMC article.

9

Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity.

Martin AM, Nolan D, Gaudieri S, Phillips E, Mallal S. Martin AM, et al. Among authors: nolan d. Pharmacogenomics. 2004 Sep;5(6):643-55. doi: 10.1517/14622416.5.6.643. Pharmacogenomics. 2004. PMID: 15335286 Review.

10

Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts.

Martin AM, Nolan D, James I, Cameron P, Keller J, Moore C, Phillips E, Christiansen FT, Mallal S. Martin AM, et al. Among authors: nolan d. AIDS. 2005 Jan 3;19(1):97-9. doi: 10.1097/00002030-200501030-00014. AIDS. 2005. PMID: 15627041

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

622 results

Search Page